In addition, the T-DARPins have allowed us to map the TBXT regulome, which provides a resource that will inform future fundamental and translational studies and has enabled the discovery of an essential signaling axis that can be targeted with clinically approved drugs and thus may represent an immediately actionable therapeutic opportunity in patients with chordoma. Here, TBXT is linked to chordoma.